|
Suppliers for CAS
60719-84-8
|
Properties | | CAS |
60719-84-8 | | Formula |
C10H9N3O | | EINECS |
262-390-0 |
|
|
12 Registered suppliers
Simagchem Corporation
P.R.China
Xingrui Industry Co., Limited
P.R.China
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C10H9N3O Molecular Weight: 187.2 Hazard Symbols: T,Xn UN Number: UN 2811 6.1/PG 3 WGKGermany: 3 PackingGroup: III HS Code: 29333999
More details are to be found here
Hangzhou Lingrui Chemical Co., Ltd.
P.R.China
Molecular Formula: C10H9N3O Molecular Weight: 187.2 Hazard Symbols: T,Xn UN Number: UN 2811 6.1/PG 3 WGKGermany: 3 PackingGroup: III HS Code: 29333999
More details are to be found here
Skyrun Industrial Co., Ltd.
P.R.China
Molecular Formula: C10H9N3O Molecular Weight: 187.2 Hazard Symbols: T,Xn UN Number: UN 2811 6.1/PG 3 WGKGermany: 3 PackingGroup: III HS Code: 29333999
More details are to be found here
BOC Sciences
USA
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
Shandong SanYoung Industry Co., Ltd
P.R.China
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
Xiamen Equation Chemical Co.,Ltd
P.R.China
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
AK Scientific, Inc.
USA
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
BuGuCh & Partners
Germany
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Amrinone is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It has the ability to stimulate calcium ion influx into the cardiac cell. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator. It acts by inhibiting the breakdown of both cAMP and cGMP by the phosphodiesterase (PDE3) enzyme. It is a drug that may improve the prognosis in patients with congestive heart failure. It has been shown to increase the contractions initiated in the heart by high gain calcium induced calcium release (CICR). It was developed by Sanofi and has been listed. - Molecular Weight :187.20
- Boiling Point :451.5±45.0 °C | Condition: Press: 760 Torr
- Melting Point :295 °C (decomp)
- Purity :98%
Molecular Formula : C10H9N3O Canonical SMILES : C1=CN=CC=C1C2=CNC(=O)C(=C2)N InChI : InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)
InChIKey :
RNLQIBCLLYYYFJ-UHFFFAOYSA-N
Solubility :
DMSO (Slightly), Methanol (Slightly)
Appearance :
Pale Beige to Yellow Solid
Application :
Amrinone is a simple, non-glycoside cardiotonic agent. It provides protection against ischemia-reperfusion injury in kidney, liver, and heart. It is used in the treatment of congestive heart failure. It increases cardiac contractility as a vasodilator.
Storage : 2-8°C
Synonyms :
Inamrinone;Wincoram;Inocor;Cordemcura;Win-40680;Win40680;3-Amino-5-pyridin-4-yl-1H-pyridin-2-one
More details are to be found here
Detailed information on the suppliers of
|
details
details